Cingulate (CING) Cash & Equivalents (2021 - 2026)
Cingulate (CING) posted Cash & Equivalents of $28.4 million for Q2 2026.
Powered by 
Analysis
Cingulate (CING) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Cingulate's Cash & Equivalents came in at $10.95 million, down 10.3% from FY2024.
- Annual Cash & Equivalents shows a four-year compound annual growth rate of -9.7% (FY2021 to FY2025).
- In prior years, Cingulate's Cash & Equivalents was $12.21 million in FY2024, $52,416 in FY2023 (-99.0%), $5.36 million in FY2022 (-67.5%) and $16.49 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents in data going back to Q4 2021.
- On a year-over-year basis, Cash & Equivalents increased in two of the last four quarters, with growth averaging 277.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2025, with growth of 754.6%; the weakest was Q4 2023, with a decline of 99.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Cingulate | 62.17 Mn | 7.18 Mn | - | 28.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.40 Mn |
| Dec 31, 2025 | 10.95 Mn |
| Sep 30, 2025 | 6.12 Mn |
| Mar 31, 2025 | 9.52 Mn |
| Dec 31, 2024 | 12.21 Mn |
| Sep 30, 2024 | 10.04 Mn |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 52,416.00 |
| Sep 30, 2023 | 1.99 Mn |
| Jun 30, 2023 | 349,831.00 |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 9.80 Mn |
| Jun 30, 2022 | 8.20 Mn |
| Mar 31, 2022 | 12.61 Mn |
| Dec 31, 2021 | 16.49 Mn |
API Access
Cingulate Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CING&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CING", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CING&period=max&api_key=YOUR_API_KEY");
const data = await res.json();